PLP1 and Pelizeaus-Merzbacher spectrum disorder: Additionally, the knockdown of PLP1 using the CRIPSR-Cas9 system or RNA interference is also available for gene therapy as clinical treatment with plp1 gene duplication in PMD patients, as described above.